Search Results - "Billauer, Hana"

A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism by Pribluda, Ariel, Elyada, Ela, Wiener, Zoltan, Hamza, Haya, Goldstein, Robert E., Biton, Moshe, Burstain, Ido, Morgenstern, Yael, Brachya, Guy, Billauer, Hana, Biton, Sharon, Snir-Alkalay, Irit, Vucic, Domagoj, Schlereth, Katharina, Mernberger, Marco, Stiewe, Thorsten, Oren, Moshe, Alitalo, Kari, Pikarsky, Eli, Ben-Neriah, Yinon

“…Senescence, perceived as a cancer barrier, is paradoxically associated with inflammation, which promotes tumorigenesis. Here, we characterize a distinct…”
Get full text

Modified PEG-anilinoquinazoline derivatives as potential EGFR PET agents by Dissoki, Samar, Eshet, Renana, Billauer, Hana, Mishani, Eyal

“…Inhibition of epidermal growth factor receptor tyrosine kinase (EGFR‐TK) has emerged as a major approach for cancer‐targeted therapy. Consequently, there has…”
Get full text

Abstract 4609: Plixorafenib (plixo) synergizes with MEK inhibitors (MEKi) in MAPK pathway inhibition in BRAF V600 and non V600 alterations, with higher potency compared to early generation BRAFi and pan-RAFi by Tarcic, Gabi, Cohen, Limor, Shepherd, Stacie Peacock, Levy, Natalie Filippov, Billauer, Hana, Birnbaum, Lea, Gasasa, Sara, Maor, Roey, Abu-Liel, Reham, Goldfarb, Eden

“…The efficacy of BRAFi in V600 mutated tumors is established and requires effective inhibition of the MAPK pathway. However, the use approved BRAFi leads to…”
Get full text

Labeled 3-aryl-4-indolylmaleimide derivatives and their potential as angiogenic PET biomarkers by Ilovich, Ohad, Billauer, Hana, Dotan, Sharon, Mishani, Eyal

“…New 3-aryl-4-indolylmaleimide derivatives were synthesized and evaluated as potential PET biomarkers for monitoring angiogenic processes. In a continued effort…”
Get full text

A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism by Pribluda, Ariel, Elyada, Ela, Wiener, Zoltan, Hamza, Haya, Goldstein, Robert E., Biton, Moshe, Burstain, Ido, Morgenstern, Yael, Brachya, Guy, Billauer, Hana, Biton, Sharon, Snir-Alkalay, Irit, Vucic, Domagoj, Schlereth, Katharina, Mernberger, Marco, Stiewe, Thorsten, Oren, Moshe, Alitalo, Kari, Pikarsky, Eli, Ben-Neriah, Yinon

Get full text

Antihyperglycaemic activity of 2,4:3,5‐dibenzylidene‐D‐xylose‐diethyl dithioacetal in diabetic mice by Gruzman, Arie, Elgart, Anna, Viskind, Olga, Billauer, Hana, Dotan, Sharon, Cohen, Guy, Mishani, Eyal, Hoffman, Amnon, Cerasi, Erol, Sasson, Shlomo

“…We have recently generated lipophilic D‐xylose derivatives that increase the rate of glucose uptake in cultured skeletal muscle cells in an AMP‐activated…”
Get full text

Structure–Activity Relationship and Preclinical Evaluation of Carbon-11-Labeled Ammonium Salts as PET–Myocardial Perfusion Imaging Agents by Ilovich, Ohad, Abourbeh, Galith, Bocher, Moshe, Freedman, Nanette, Billauer, Hana, Dotan, Sharon, Danenberg, Haim D., Mishani, Eyal

“…Background Due to the limited availability of suitable positron emission tomography (PET) tracers, the majority of myocardial perfusion imaging (MPI) scans is…”
Get full text

Novel and Simple Carbon-11-Labeled Ammonium Salts as PET Agents for Myocardial Perfusion Imaging by Ilovich, Ohad, Billauer, Hana, Dotan, Sharon, Freedman, Nanette M. T., Bocher, Moshe, Mishani, Eyal

“…Background Positron emission tomography (PET) has clear advantages over single photon emission computed tomography (SPECT) in the field of myocardial perfusion…”
Get full text

Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by nicotine administration and neural stem cell transplantation by Billauer-Haimovitch, Hana, Slotkin, Theodore A., Dotan, Sharon, Langford, Rachel, Pinkas, Adi, Yanai, Joseph

“…Identifying the mechanisms underlying the adverse effects of developmental neurotoxicants enables the design of therapies that can potentially reverse…”
Get full text